STONERIDGE INVESTMENT PARTNERS LLC

Position in IRD — Opus Genetics, Inc.

CIK 1108831 RADNOR, PA

Position in IRD

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$47

New position

Shares Held

12,695

first reported quarter

Ownership

0.015%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#102

of 102 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 84% Shared 16% None 0%

Healthcare · as of Jun 30, 2026

STONERIDGE INVESTMENT PARTNERS LLC holds $518,854 across 6 Biotechnology names. IRD ranks #5 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	5,221	$368,863
2	CRMD	CorMedix Inc.	13,129	$103,062
3	NAGE	Niagen Bioscience, Inc.	14,477	$46,181
4	REGN	Regeneron Pharmaceuticals, Inc.	861	$657
5	IRD	Opus Genetics, Inc. This page	12,695	$47
6	ABUS	Arbutus Biopharma Corp	10,125	$44

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$47	12,695	—	Shares	Sole	2026-08-06
No filing history on record for this holder in this stock.